Deal Details

Calyx Combines with Invicro

Healthcare

Calyx combination with Invicro, a subsidiary of Konica Minolta

Summary

Calyx Services Inc. (“Calyx” or the “Company”) has announced a strategic combination with Invicro LLC (“Invicro”), a subsidiary of Konica Minolta, Inc.

The transaction is subject to various regulatory approvals and customary closing conditions.

Baird served as exclusive financial advisor to Calyx on this transaction.

About

Calyx is a leading global technology-enabled service provider for medical imaging and IRT/RTSM (Interactive Response Technology/Randomized Trial Supply Management) for drug developers and the global clinical research community. Calyx's market-leading service, scientific knowledge, expertise and technology offering help speed up the delivery of life-saving treatments to millions of patients around the world by accelerating and improving clinical trial outcomes. With operations in six countries, the Company provides 24/7 services to most of the world's leading pharma and biotech companies. Calyx is headquartered in Nottingham, United Kingdom.

Invicro is a next-generation quantitative imaging biomarker company focused on accelerating the discovery and development of life-changing medicines. With laboratories in the U.S., U.K., India, Japan and China, Invicro is a global research partner to numerous pharmaceutical, biotech and contract research organizations, leveraging its platform to combine best-in-class expertise, imaging biomarkers, core lab services, analytics and software. Its medical imaging capabilities are helping to achieve better patient outcomes in key therapeutic areas including oncology, central nervous system and respiratory, as well as meet the growing demand for enhanced imaging and new therapies in fast-growing specialties such as radiotherapy, gastroenterology, inflammation, fibrosis and mitochondrial imaging. Invicro is headquartered in Needham, Massachusetts.

Healthcare

Calyx combination with Invicro, a subsidiary of Konica Minolta